Reiko Watanabe Selected Research

Antibodies

1/2023	Patients with B-cell malignancies experience reduced antibody responses with class switching defect following BNT162b2 SARS-CoV-2 vaccination.
4/2022	Prognostic impact of count of extratumoral lymphatic permeation in lung adenocarcinoma and its relation to the immune microenvironment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Reiko Watanabe Research Topics

Disease

41	Neoplasms (Cancer) 12/2023 - 05/2002
7	Osteoporosis 01/2019 - 09/2013
4	Carcinoma (Carcinomatosis) 10/2023 - 06/2010
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 06/2008
4	Glioma (Gliomas) 10/2018 - 12/2012
4	Neoplasm Metastasis (Metastasis) 08/2018 - 01/2013
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2018 - 06/2002
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 08/2002
3	Inflammation (Inflammations) 01/2023 - 08/2016
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2021 - 01/2020
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 06/2002
3	Body Weight (Weight, Body) 01/2018 - 01/2008
3	Multiple Myeloma 04/2015 - 05/2011
3	Glioblastoma (Glioblastoma Multiforme) 07/2013 - 04/2011
3	Periodontal Diseases (Periodontal Disease) 02/2013 - 11/2010
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2023 - 09/2017
2	Residual Neoplasm 07/2023 - 04/2022
2	Necrosis 01/2023 - 04/2021
2	Adenocarcinoma of Lung 04/2022 - 05/2012
2	Philadelphia Chromosome 01/2021 - 01/2021
2	Meningioma (Meningiomas) 04/2019 - 01/2014
2	Fatty Liver 01/2019 - 10/2016
2	Hemorrhage 01/2017 - 05/2010
2	Rheumatoid Arthritis 01/2017 - 01/2014
2	Liver Diseases (Liver Disease) 01/2017 - 12/2012
2	Diabetic Nephropathies (Diabetic Nephropathy) 10/2016 - 10/2013
2	Cysts 04/2014 - 12/2011
2	Tinnitus 02/2014 - 05/2013
2	Prostatic Neoplasms (Prostate Cancer) 01/2013 - 09/2004
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2012 - 06/2010
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2010 - 02/2007
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2023
1	Esophageal Squamous Cell Carcinoma 07/2023
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 07/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2023
1	Triple Negative Breast Neoplasms 04/2022
1	Rectal Neoplasms (Rectal Cancer) 04/2022
1	Leukemia 01/2021
1	Hematologic Diseases (Blood Diseases) 01/2021
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Chronic Renal Insufficiency 11/2019

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 10/2023 - 02/2009
5	Vitamin D FDA LinkGeneric 01/2018 - 09/2013
4	Indicators and Reagents (Reagents)IBA 01/2023 - 09/2015
4	Biomarkers (Surrogate Marker)IBA 12/2018 - 04/2011
3	B7-H1 AntigenIBA 12/2023 - 12/2018
3	Bortezomib (Velcade)FDA Link 04/2015 - 05/2011
3	Peptides (Polypeptides)IBA 01/2014 - 06/2012
3	DNA (Deoxyribonucleic Acid)IBA 07/2013 - 04/2011
2	Messenger RNA (mRNA)IBA 08/2023 - 01/2009
2	AntibodiesIBA 01/2023 - 04/2022
2	Rituximab (Mabthera)FDA Link 01/2023 - 11/2010
2	Mucin-1 (CA 15-3 Antigen)IBA 04/2022 - 04/2019
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2018
2	AntioxidantsIBA 11/2019 - 02/2013
2	Epithelial Cell Adhesion MoleculeIBA 01/2019 - 01/2013
2	Dasatinib (BMS 354825)FDA Link 07/2018 - 02/2016
2	CalciumIBA 01/2018 - 09/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 11/2013
2	Triglycerides (Triacylglycerol)IBA 01/2018 - 12/2008
2	GlucocorticoidsIBA 01/2018 - 08/2016
2	Alkylating AgentsIBA 01/2017 - 04/2011
2	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 01/2014
2	Immunomodulating AgentsIBA 04/2015 - 03/2013
2	MucinsIBA 04/2014 - 12/2011
2	Caseins (Casein)FDA Link 10/2013 - 04/2009
2	Temozolomide (Temodar)FDA LinkGeneric 12/2012 - 04/2011
2	Phosphopyruvate Hydratase (Enolase)IBA 06/2012 - 09/2010
1	Azacitidine (5 Azacytidine)FDA Link 10/2023
1	Interleukin-10 (Interleukin 10)IBA 08/2023
1	C-Reactive ProteinIBA 01/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023
1	Histones (Histone)IBA 01/2023
1	AlbuminsIBA 01/2023
1	BNT162 VaccineIBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	mRNA VaccinesIBA 01/2023
1	Aldehyde Dehydrogenase 1 FamilyIBA 04/2022
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	fludarabineIBA 01/2020
1	Viral DNAIBA 01/2020
1	thymoglobulin FDA Link 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	AcidsIBA 11/2019

Therapy/Procedure

14	Therapeutics 01/2023 - 06/2002
9	Drug Therapy (Chemotherapy) 05/2017 - 05/2002
6	Cell Transplantation 11/2021 - 11/2019
6	Radiotherapy 01/2014 - 02/2009
5	Hematopoietic Stem Cell Transplantation 10/2023 - 06/2008
2	Homologous Transplantation 10/2023 - 06/2002
2	Neoadjuvant Therapy 07/2023 - 04/2022
2	Transplantation 09/2017 - 06/2002
2	Activities of Daily Living (ADL) 08/2016 - 05/2013
2	Immunotherapy 04/2014 - 12/2012
1	Prostatectomy (Retropubic Prostatectomy) 03/2022
1	Nephrectomy 04/2021
1	Central Venous Catheters 01/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2020